Sato, K., Nakayama, I., Yura, M., Sato, A., Suzuki, M., Kadota, T., Nakamura, M., Sakamoto, N., Hashimoto, T., Sakashita, S., Wakabayashi, M., Shoji, H., Yoshikawa, T., Daiko, H., Kato, K., Yoshino, T., Yano, T., Fujita, T., Kinoshita, T., Shitara, K. (2026). An open label phase 2 study of total neoadjuvant therapy (TNT) consisting of FLOT with pembrolizumab and short radiation for patients with locally advanced gastroesophageal junction adenocarcinoma (EPOC2301).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps464